TELA Bio Statistics Share Statistics TELA Bio has 39.62M
shares outstanding. The number of shares has increased by 60.05%
in one year.
Shares Outstanding 39.62M Shares Change (YoY) 60.05% Shares Change (QoQ) 0.01% Owned by Institutions (%) 54.32% Shares Floating 31.4M Failed to Deliver (FTD) Shares 810 FTD / Avg. Volume 1.01%
Short Selling Information The latest short interest is 460.5K, so 1.16% of the outstanding
shares have been sold short.
Short Interest 460.5K Short % of Shares Out 1.16% Short % of Float 1.47% Short Ratio (days to cover) 4.59
Valuation Ratios The PE ratio is -2.28 and the forward
PE ratio is -3.2.
TELA Bio's PEG ratio is
0.07.
PE Ratio -2.28 Forward PE -3.2 PS Ratio 1.24 Forward PS 0.6 PB Ratio 3.03 P/FCF Ratio -2.02 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for TELA Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.01,
with a Debt / Equity ratio of 1.46.
Current Ratio 5.01 Quick Ratio 4.19 Debt / Equity 1.46 Debt / EBITDA -1.32 Debt / FCF -0.98 Interest Coverage -6.45
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $331.58K Profits Per Employee $-181.06K Employee Count 209 Asset Turnover 0.8 Inventory Turnover 1.78
Taxes Income Tax -144K Effective Tax Rate 0.38%
Stock Price Statistics The stock price has increased by -37.69% in the
last 52 weeks. The beta is 0.84, so TELA Bio's
price volatility has been higher than the market average.
Beta 0.84 52-Week Price Change -37.69% 50-Day Moving Average 1.81 200-Day Moving Average 2 Relative Strength Index (RSI) 44.12 Average Volume (20 Days) 79,891
Income Statement In the last 12 months, TELA Bio had revenue of 69.3M
and earned -37.84M
in profits. Earnings per share was -1.33.
Revenue 69.3M Gross Profit 46.49M Operating Income -34.12M Net Income -37.84M EBITDA -31.68M EBIT -32.7M Earnings Per Share (EPS) -1.33
Full Income Statement Balance Sheet The company has 52.67M in cash and 41.67M in
debt, giving a net cash position of 11M.
Cash & Cash Equivalents 52.67M Total Debt 41.67M Net Cash 11M Retained Earnings -358.73M Total Assets 67.54M Working Capital 41.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -41.59M
and capital expenditures -989K, giving a free cash flow of -42.58M.
Operating Cash Flow -41.59M Capital Expenditures -989K Free Cash Flow -42.58M FCF Per Share -1.49
Full Cash Flow Statement Margins Gross margin is 67.08%, with operating and profit margins of -49.23% and -54.6%.
Gross Margin 67.08% Operating Margin -49.23% Pretax Margin -54.81% Profit Margin -54.6% EBITDA Margin -45.72% EBIT Margin -49.23% FCF Margin -61.45%
